CD86 and viral infectious disease: This activity may contribute to the therapeutic effects of Pom in these tumors, since an effective T-cell immune response against virus infection requires expression of MHC-I and/or co-stimulatory molecules such as B7-2 and ICAM-1 on target cells45.